Subscribe to stay informed!
After pushing the launch of its new cellulite treatment, Qwo, to this spring due to the pandemic, Malvern-based Endo International has been building momentum…
Endo International, the Dublin-based pharmaceutical company with its U.S. headquarters in Malvern, has announced plans to restructure the company and eliminate 560 jobs…
Malvern-based Endo Pharmaceuticals has agreed to acquire BioSpecifics Technologies, a 20-year-old company based in Wilmington, for around $658 million, writes Joseph DiStefano…
Endo International, the Dublin-based pharmaceutical company with its U.S. headquarters in Malvern, has received marketing approval from the FDA for its injectable drug…
Before we send you to this site, please subscribe to our daily newsletter.